360 related articles for article (PubMed ID: 24259517)
1. Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.
Perluigi M; Di Domenico F; Buttterfield DA
Proteomics Clin Appl; 2014 Feb; 8(1-2):73-85. PubMed ID: 24259517
[TBL] [Abstract][Full Text] [Related]
2. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.
Di Domenico F; Coccia R; Cocciolo A; Murphy MP; Cenini G; Head E; Butterfield DA; Giorgi A; Schinina ME; Mancuso C; Cini C; Perluigi M
Biochim Biophys Acta; 2013 Aug; 1832(8):1249-59. PubMed ID: 23603808
[TBL] [Abstract][Full Text] [Related]
3. Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.
Butterfield DA; Di Domenico F; Swomley AM; Head E; Perluigi M
Biochem J; 2014 Oct; 463(2):177-89. PubMed ID: 25242166
[TBL] [Abstract][Full Text] [Related]
4. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.
Di Domenico F; Pupo G; Tramutola A; Giorgi A; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2014 Jun; 71():270-280. PubMed ID: 24675226
[TBL] [Abstract][Full Text] [Related]
5. Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology.
Tramutola A; Di Domenico F; Barone E; Arena A; Giorgi A; di Francesco L; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
Antioxid Redox Signal; 2017 Mar; 26(7):280-298. PubMed ID: 27627691
[TBL] [Abstract][Full Text] [Related]
6. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
Barone E; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
[TBL] [Abstract][Full Text] [Related]
7. Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.
Wegiel J; Flory M; Kuchna I; Nowicki K; Wegiel J; Ma SY; Zhong N; Bobrowicz TW; de Leon M; Lai F; Silverman WP; Wisniewski T
Acta Neuropathol Commun; 2022 Jan; 10(1):2. PubMed ID: 34983655
[TBL] [Abstract][Full Text] [Related]
8. An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach.
Cenini G; Fiorini A; Sultana R; Perluigi M; Cai J; Klein JB; Head E; Butterfield DA
Free Radic Biol Med; 2014 Nov; 76():89-95. PubMed ID: 25151119
[TBL] [Abstract][Full Text] [Related]
9. Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome.
Martínez-Cué C; Rueda N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962300
[TBL] [Abstract][Full Text] [Related]
10. Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome.
Di Domenico F; Tramutola A; Barone E; Lanzillotta C; Defever O; Arena A; Zuliani I; Foppoli C; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Perluigi M
Redox Biol; 2019 May; 23():101162. PubMed ID: 30876754
[TBL] [Abstract][Full Text] [Related]
11. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
12. Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules.
Lanzillotta C; Di Domenico F
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670211
[TBL] [Abstract][Full Text] [Related]
13. Alteration of gene expression in Down's syndrome (DS) brains: its significance in neurodegeneration.
Sawa A
J Neural Transm Suppl; 2001; (61):361-71. PubMed ID: 11771759
[TBL] [Abstract][Full Text] [Related]
14. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
Helguera P; Pelsman A; Pigino G; Wolvetang E; Head E; Busciglio J
J Neurosci; 2005 Mar; 25(9):2295-303. PubMed ID: 15745955
[TBL] [Abstract][Full Text] [Related]
15. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
16. Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.
Head E; Lott IT; Wilcock DM; Lemere CA
Curr Alzheimer Res; 2016; 13(1):18-29. PubMed ID: 26651341
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.
Butterfield DA; Perluigi M; Sultana R
Eur J Pharmacol; 2006 Sep; 545(1):39-50. PubMed ID: 16860790
[TBL] [Abstract][Full Text] [Related]
18. Neurological phenotypes for Down syndrome across the life span.
Lott IT
Prog Brain Res; 2012; 197():101-21. PubMed ID: 22541290
[TBL] [Abstract][Full Text] [Related]
19. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
[TBL] [Abstract][Full Text] [Related]
20. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
